Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001405865 | SCV001607805 | likely benign | Myofibrillar myopathy 4 | 2023-10-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002320362 | SCV002610839 | likely benign | Cardiovascular phenotype | 2019-09-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001091335 | SCV001921821 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001091335 | SCV001963104 | likely benign | not provided | no assertion criteria provided | clinical testing |